Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic testing for ataxia in North America.

N T Potter1, M A Nance,

  • 1Neurogenetics Laboratory, Developmental and Genetic Center, The University of Tennessee Medical Center, Knoxville, TN, USA. npotter@mc.utmck.edu

Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology
|November 7, 2000
PubMed
Summary

Molecular testing for spinocerebellar ataxias (SCAs) shows high accuracy in allele sizing across North American labs. Further research is needed to correlate intermediate CAG repeat lengths with specific SCA phenotypes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.

Journal of neurology·2017
Same author

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2016
Same author

New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system).

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2016
Same author

HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2016
Same author

Incomplete nonsense-mediated decay facilitates detection of a multi-exonic deletion mutation in SGCE.

Clinical genetics·2012
Same author

Apolipoprotein E controls the risk and age at onset of Parkinson disease.

Neurology·2004

Area of Science:

  • Genetics
  • Neurology
  • Molecular Diagnostics

Background:

  • Established the Ataxia Molecular Diagnostics Testing Group to assess molecular testing for autosomal dominant cerebellar ataxias.
  • Focused on spinocerebellar ataxia types 1-3, 6, 7, and dentatorubral-pallidoluysian atrophy in North America.

Purpose of the Study:

  • Generate quantitative proficiency and outcomes data for ataxia molecular diagnostic testing.
  • Evaluate the performance of North American laboratories in genetic testing for SCAs.

Main Methods:

  • Identified 24 North American laboratories offering ataxia gene testing.
  • 18 laboratories participated, completing technical/clinical surveys and molecular proficiency tests.
  • Analyzed test volumes and proficiency testing results for allele sizing accuracy.

Related Experiment Videos

Main Results:

  • 10 of 18 labs reported test volumes, performing 2,240 tests with ~5% positive results for CAG repeat expansions.
  • 100% of participating laboratories correctly genotyped all samples.
  • 93% and 90% of labs accurately sized normal and expanded alleles, respectively.

Conclusions:

  • Proficiency testing revealed minimal inter-laboratory variation in allele sizing accuracy.
  • Further phenotype/genotype correlation studies are required for intermediate CAG repeat lengths in SCA-1, SCA-2, and SCA-7.